Example: Heart Attack
Clinical Trials Sponsored by Refocus Group, Inc.
Total 3 results
-
NCT03811249Enrolling by invitationConditions: Presbyopia
-
NCT02374671CompletedConditions: Presbyopia
-
NCT01166568CompletedConditions: Presbyopia
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Adrenoleukodystrophy
- Carotid-Cavernous Sinus Fistula
- Choristoma
- Fissure in Ano
- Latent Tuberculosis
- Neurocysticercosis
- Osteoarthritis, Knee
- Osteosarcoma, Juxtacortical
- Plague
- Renal Artery Obstruction
- Sex Chromosome Aberrations
- Unilateral Breast Neoplasms
- Vogt-Koyanagi-Harada Disease
- View Full List
Sponsors and Collaborators
- Camargo Pharmaceutical Services
- Control Delivery Systems
- Etablissement Francais du Sang
- Hospital Universitario La Paz
- Hospital of South West Denmark
- Io Therapeutics
- Janssen-Cilag Ltd.,Thailand
- National Heart Foundation, Australia
- National Research System-College of Family Physicians of Canada
- New York University
- Pine Street Foundation
- Reading Scientific Services Ltd.
- Universal Enterprises
- View Full List
Drug Interventions
- Acetaminophen, hydrocodone drug combination
- Adrenergic alpha-Agonists
- Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination
- Calciferol
- Dipeptidyl-Peptidase IV Inhibitors
- Diphenidol
- Efaproxiral
- Glucosamine
- Halobetasol
- Kaolin
- Procyanidin
- Serotonin 5-HT3 Receptor Antagonists
- Valdecoxib
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations